Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation Hermann M. Behre, Colin.

Slides:

Advertisements

Similar presentations

A randomized controlled trial comparing the efficacy and safety of two HMG preparations gaining their LH bioactivity from different HCG sources Gillian.

Advertisements

GnRH agonist and GnRH antagonist protocols in ovarian stimulation: differential regulation pathway of aromatase expression in human granulosa cells Mohamad.

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis

Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis Sesh Kamal Sunkara, Jyotsna Pundir,

Modified natural cycle IVF and mild IVF: a 10 year Swedish experience

Kay Neumann, Georg Griesinger Reproductive BioMedicine Online

Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P. C

Time-lapse culture with morphokinetic embryo selection improves pregnancy and live birth chances and reduces early pregnancy loss: a meta-analysis Csaba.

Blastocyst-stage versus cleavage-stage embryo transfer in women with high oestradiol concentrations: randomized controlled trial Eman A. Elgindy, Ahmed.

Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase TG Lainas, IA Sfontouris, IZ Zorzovilis, GK Petsas,

J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F

J. C. Castillo, M. Dolz, E. Bienvenido, L. Abad, E. M. Casañ, F

Effect of mid-follicular phase recombinant LH versus urinary HCG supplementation in poor ovarian responders undergoing IVF – a prospective double-blinded.

Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial Malin Nylander, Signe Frøssing, Helle V. Clausen,

Bruce S. Shapiro, Said T. Daneshmand, Humberto Restrepo, Forest C

A. Osman, J. Pundir, M. Elsherbini, S. Dave, T. El-Toukhy, Y. Khalaf

Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF Bart C.J.M. Fauser, Michael.

Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction Antonio La Marca, Giovanni D’Ippolito

Advanced glycation end product concentrations in follicular fluid of women undergoing IVF/ICSI with a GnRH agonist protocol Qi Yao, Yuanjiao Liang, Yong.

No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH George Griesinger, Daniel B. Shapiro, Efstratios.

Clinical utility of newly developed highly purified human menopausal gonadotrophins: a randomized controlled trial Hwa Seon Koo, Hwang Kwon, Doo Seok.

Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial Christophe Blockeel, Sara Engels, Michel De Vos, Patrick Haentjens,

In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation

A randomized controlled trial comparing the efficacy and safety of two HMG preparations gaining their LH bioactivity from different HCG sources Gillian.

New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation Giovanna Sighinolfi,

A multi-centre phase 3 study comparing efficacy and safety of Bemfola® versus Gonal- f® in women undergoing ovarian stimulation for IVF M. Rettenbacher,

Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of.

Why are reproductive cancers more common in nulliparous women?

Ovarian stimulation protocols for IVF: is more better than less?

Maternal concentrations of human chorionic gonadotrophin in very early IVF pregnancies and duration of pregnancy: a follow-up study Tom G. Tanbo, Manuela.

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Sarah McCredie, William Ledger, Christos A. Venetis

Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study A. Nasr Reproductive BioMedicine Online

Ongoing pregnancies from early retrieval of prematurely developing antral follicles after DHEA supplementation Murat Sönmezer, Aylin Pelin Çil, Kutluk.

Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis Georg Griesinger, Robert Boostanfar, Keith.

M. Dieterich, M. Bolz, T. Reimer, S. Costagliola, B. Gerber

Impact of ovarian endometrioma on ovarian responsiveness and IVF: a systematic review and meta-analysis Chun Yang, Yuhong Geng, Yanhui Li, Chunyan Chen,

Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa F. Olivennes, G. Trew,

Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial Vivian Chi Yan Lee, Carina Chi Wai Chan,

Influence of paternal age on ongoing pregnancy rate at eight weeks' gestation in assisted reproduction Aukje Marieke Meijerink, Liliana Ramos, Kathrin.

Jyotsna Pundir, Sesh Kamal Sunkara, Tarek El-Toukhy, Yacoub Khalaf

Spontaneous ovulation versus HCG triggering for timing natural-cycle frozen–thawed embryo transfer: a randomized study Ariel Weissman, Eran Horowitz,

A retrospective analysis of ovarian stimulation with letrozole in women undergoing artificial insemination by donor X.J. Sun, L. Jiang, L.C. Ji, R. Nie,

Mid-follicular LH supplementation in women aged 35–39 years undergoing ICSI cycles: a randomized controlled study R Matorras, B Prieto, A Exposito, R.

A unique biological in-vivo model to evaluate follicular development during in-vitro maturation treatment S.E. Elizur, W.Y. Son, H. Clarke, D. Morris,

V Isachenko, E Isachenko, R Kreienberg, M Woriedh, JM Weiss

Clinical Assessment of Recombinant Human Follicle-Stimulating Hormone in Stimulating Ovarian Follicular Development Before In Vitro Fertilization fn1

Michael J. Levy, William Ledger, Efstratios M. Kolibianakis, Pieta C

Intra-cycle variation of the uterine cavity indentation assessed with three-dimensional ultrasound in natural and stimulated cycles Sotirios H. Saravelos,

Low-dose HCG may improve pregnancy rates and lower OHSS in antagonist cycles: a meta-analysis IP Kosmas, K Zikopoulos, I Georgiou, E Paraskevaidis, C.

Stephen C. Collins, Esther Chan Reproductive BioMedicine Online

GnRH antagonist pre-treatment: one centre's experience for IVF–ICSI cycle scheduling Veronique Viardot-Foucault, Sadhana Nadarajah, Weng Kit Lye, Heng.

Clinical significance of first-trimester intrauterine haematomas detected in pregnancies achieved by IVF-embryo transfer Lan Xiang, Zhaolian Wei, Juan.

The effect of protein supplement concentration in embryo transfer medium on clinical outcome of IVF/ICSI cycles: a prospective, randomized clinical trial

Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature Micah J. Hill, Gary Levy, Eric D. Levens

Cryopreserved embryo transfer: adjacent or non-adjacent to failed fresh long GnRH- agonist protocol IVF cycle Alexander Volodarsky-Perel, Talia Eldar-Geva,

Jing Zhao, Qiong Zhang, Yonggang Wang, Yanping Li

Nigel Pereira, Anna Voskuilen-Gonzalez, Kolbe Hancock, Jovana P

Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF Thomas Freour, Lionel Dessolle, Miguel Jean, Damien Masson,

Ovarian reserve screening before contraception?

Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH Basil C. Tarlatzis,

Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study E.G. Papanikolaou, C. Bourgain, H. Fatemi,

John Yovich, James Stanger, Peter Hinchliffe

Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins:

Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis Ernesto Bosch, M.D., Elena.

Intensified ovarian stimulation in a GnRH antagonist protocol with agonist triggering: a prospective, clinical feasibility study Georg Griesinger, Henriette.

Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists

Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles

Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era? Antonio La Marca, Martina Capuzzo Reproductive.

Presentation transcript:

Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation Hermann M. Behre, Colin M. Howles, Salvatore Longobardi Reproductive BioMedicine Online Volume 31, Issue 3, Pages 339-346 (September 2015) DOI: 10.1016/j.rbmo.2015.06.002 Copyright © 2015 The Authors Terms and Conditions

Figure 1 Patient disposition for those receiving recombinant human follicle-stimulating hormone (rhFSH) plus recombinant human luteinizing hormone (rhLH) (2:1) from stimulation day 1 (group A), or rhFSH from days 1–5, then rhFSH plus rhLH (2:1) from day 6 (group B). Clinical pregnancy was defined as the presence of at least one gestational sac in the uterus with fetal heart activity confirmed by ultrasound on days 35–42 after HCG. GnRH = gonadotrophin-releasing hormone; mITT = modified intention-to-treat; OHSS = ovarian hyperstimulation syndrome. Reproductive BioMedicine Online 2015 31, 339-346DOI: (10.1016/j.rbmo.2015.06.002) Copyright © 2015 The Authors Terms and Conditions